Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 5
2022 3
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean lancaster j[au] (1,001 results)?
COVID-19 Severity and Thrombo-Inflammatory Response Linked to Ethnicity.
Heissig B, Salama Y, Iakoubov R, Vehreschild JJ, Rios R, Nogueira T, Vehreschild MJGT, Stecher M, Mori H, Lanznaster J, Adachi E, Jakob C, Tabe Y, Ruethrich M, Borgmann S, Naito T, Wille K, Valenti S, Hower M, Hattori N, Rieg S, Nagaoka T, Jensen BE, Yotsuyanagi H, Hertenstein B, Ogawa H, Wyen C, Kominami E, Roemmele C, Takahashi S, Rupp J, Takahashi K, Hanses F, Hattori K, On Behalf Of The Leoss Study Group. Heissig B, et al. Among authors: lanznaster j. Biomedicines. 2022 Oct 12;10(10):2549. doi: 10.3390/biomedicines10102549. Biomedicines. 2022. PMID: 36289811 Free PMC article.
Outcomes of SARS-CoV-2 Infections in Patients with Neurodegenerative Diseases in the LEOSS Cohort.
Huber MK, Raichle C, Lingor P, Synofzik M, Borgmann S, Erber J, Tometten L, Rimili W, Dolff S, Wille K, Knauss S, Piepel C, Lanznaster J, Rieg S, Prasser F, Pilgram L, Spottke A, Klockgether T, Klein C, Hopfner F, Höglinger GU; LEOSS Study Group. Huber MK, et al. Among authors: lanznaster j. Mov Disord. 2021 Apr;36(4):791-793. doi: 10.1002/mds.28554. Epub 2021 Feb 27. Mov Disord. 2021. PMID: 33638915 Free PMC article. No abstract available.
Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry.
Schmidt-Hellerau K, Raichle C, Ruethrich MM, Vehreschild JJ, Lanznaster J, Nunes de Miranda SM, Bausewein C, Vehreschild MJGT, Koll CEM, Simon ST, Hellwig K, Jensen BO, Jung N; LEOSS Study Group. Schmidt-Hellerau K, et al. Among authors: lanznaster j. Infection. 2023 Aug;51(4):1119-1126. doi: 10.1007/s15010-023-02020-z. Epub 2023 Mar 23. Infection. 2023. PMID: 36952127 Free PMC article.
First results of the "Lean European Open Survey on SARS-CoV-2-Infected Patients (LEOSS)".
Jakob CEM, Borgmann S, Duygu F, Behrends U, Hower M, Merle U, Friedrichs A, Tometten L, Hanses F, Jung N, Rieg S, Wille K, Grüner B, Klinker H, Gersbacher-Runge N, Hellwig K, Eberwein L, Dolff S, Rauschning D, von Bergwelt-Baildon M, Lanznaster J, Strauß R, Trauth J, de With K, Ruethrich M, Lueck C, Nattermann J, Tscharntke L, Pilgram L, Fuhrmann S, Classen A, Stecher M, Schons M, Spinner C, Vehreschild JJ. Jakob CEM, et al. Among authors: lanznaster j. Infection. 2021 Feb;49(1):63-73. doi: 10.1007/s15010-020-01499-0. Epub 2020 Oct 1. Infection. 2021. PMID: 33001409 Free PMC article.
COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM, Giessen-Jung C, Borgmann S, Classen AY, Dolff S, Grüner B, Hanses F, Isberner N, Köhler P, Lanznaster J, Merle U, Nadalin S, Piepel C, Schneider J, Schons M, Strauss R, Tometten L, Vehreschild JJ, von Lilienfeld-Toal M, Beutel G, Wille K; LEOSS Study Group. Rüthrich MM, et al. Among authors: lanznaster j. Ann Hematol. 2021 Feb;100(2):383-393. doi: 10.1007/s00277-020-04328-4. Epub 2020 Nov 7. Ann Hematol. 2021. PMID: 33159569 Free PMC article.
COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome.
Rüthrich MM, Khodamoradi Y, Lanznaster J, Stecher M, Tometten L, Voit F, Koll CEM, Borgmann S, Vehreschild JJ, Ole Jensen BE, Hanses F, Giessen-Jung C, Wille K, von Lilienfeld-Toal M, Beutel G; LEOSS Study Group. Rüthrich MM, et al. Among authors: lanznaster j. Oncol Res Treat. 2024;47(3):88-96. doi: 10.1159/000535267. Epub 2023 Nov 15. Oncol Res Treat. 2024. PMID: 37967545
Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases.
Linden T, Hanses F, Domingo-Fernández D, DeLong LN, Kodamullil AT, Schneider J, Vehreschild MJGT, Lanznaster J, Ruethrich MM, Borgmann S, Hower M, Wille K, Feldt T, Rieg S, Hertenstein B, Wyen C, Roemmele C, Vehreschild JJ, Jakob CEM, Stecher M, Kuzikov M, Zaliani A, Fröhlich H; LEOSS study group. Linden T, et al. Among authors: lanznaster j. Artif Intell Life Sci. 2021 Dec;1:100020. doi: 10.1016/j.ailsci.2021.100020. Epub 2021 Dec 17. Artif Intell Life Sci. 2021. PMID: 34988543 Free PMC article.
SARS-CoV-2 infection in chronic kidney disease patients with pre-existing dialysis: description across different pandemic intervals and effect on disease course (mortality).
Pilgram L, Eberwein L, Jensen BO, Jakob CEM, Koehler FC, Hower M, Kielstein JT, Stecher M, Hohenstein B, Prasser F, Westhoff T, de Miranda SMN, Vehreschild MJGT, Lanznaster J, Dolff S; LEOSS study group. Pilgram L, et al. Among authors: lanznaster j. Infection. 2023 Feb;51(1):71-81. doi: 10.1007/s15010-022-01826-7. Epub 2022 Apr 29. Infection. 2023. PMID: 35486356 Free PMC article.
Corrigendum to "Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases"[Artificial Intelligence in Life Sciences] 1(2021), 100020.
Linden T, Hanses F, Domingo-Fernández D, DeLong LN, Kodamullil AT, Schneider J, Vehreschild MJGT, Lanznaster J, Ruethrich MM, Borgmann S, Hower M, Wille K, Feldt T, Rieg S, Hertenstein B, Wyen C, Roemmele C, Vehreschild JJ, Jakob CEM, Stecher M, Kuzikov M, Zaliani A, Fröhlich H; LEOSS study group, on behalf of the COPERIMOplus Consortium. Linden T, et al. Among authors: lanznaster j. Artif Intell Life Sci. 2022 Dec;2:100032. doi: 10.1016/j.ailsci.2022.100032. Epub 2022 Feb 8. Artif Intell Life Sci. 2022. PMID: 35156080 Free PMC article.
Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease.
Pilgram L, Eberwein L, Wille K, Koehler FC, Stecher M, Rieg S, Kielstein JT, Jakob CEM, Rüthrich M, Burst V, Prasser F, Borgmann S, Müller RU, Lanznaster J, Isberner N, Tometten L, Dolff S; LEOSS Study group. Pilgram L, et al. Among authors: lanznaster j. Infection. 2021 Aug;49(4):725-737. doi: 10.1007/s15010-021-01597-7. Epub 2021 Apr 13. Infection. 2021. PMID: 33851328 Free PMC article.